Pixium Vision, a retinal implant developer looking to restore vision in the blind, has raised €15m ($20.3m) in series A backing in a round led by venture firm Sofinnova Partners. The Université Pierre et Marie Curie spin-out also attracted support from venture firms Bpifrance and Abingworth, as well as private equity firm Omnes Capital. Along…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
